Increased Serum Interleukin-10 Level in Kawasaki Disease

Yonsei Medical Journal

Volumn 37, Issue 2, 1996, Pages 125-130

  Kim, Dong Soo ^a   Lee, Hong Kyu ^b   Noh, Geun Woong ^b   Lee, Soon Il ^b   Lee, Ki Young ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Sowha Children s Hospital   (South Korea)

Author keywords

IL 10; IL 12; IL 4; Kawasaki disease

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4;

ARTICLE; BLOOD; CHILD; FEMALE; HUMAN; IMMUNOLOGY; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-4; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 0030117515     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.1996.37.2.125     Document Type: Article

References (26)

1. Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F: Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251: 70-72, 1991
2. Burdin N, Kooten CV, Galibert L, Abrams JS, Wijdened J, Banchereau J, Rousset F: Endogenous IL-6 and IL-10 contribute to the differentiation of CD40-activated human B lymphocytes. J Immunol 154: 2533-2544, 1995
3. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, Trinchieri G: Induction of interferon production by natural killer cell stimulatory factor:Characterization of the responding cells and synergy with other inducers. J Exp Med 173: 869-879, 1991
4. de Vries JE, de Waal Malefyt R: Interleukin-10 R.G. Landes Co., Austin, 1995, 70-100
5. de Waal Malefyt R, Naanen J, Spits H, Roncarolo M, de Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 and viral IL-10 strongly reduced antigen-specific human T cell proliferation by diminishing the antigen-processing capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med 174: 915-924, 1991
6. Furukawa S, Matsubara T, Jujoh K, Yone K, Sugawara T, Sasai K, Kato H, Yabuta K: Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin Immunol Immunopathol 48: 247-251, 1988
7. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizonnite R, Gubler U, Stern AS: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12(cytolytic lymphocyte maturation factor). J Immunol 147: 874-882, 1991
8. Guzman J, Fung M, Petty RE: Diagnostic value of anti-neutrophil cytoplasmic and anti-endothelial cell antibodies in early Kawasaki disease. J Pediatr 124: 917-920, 1994
9. Joyce DA, Gibbons DP, Green P, Steer JH, Feldmann M, Brennan FM: Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects onrelease of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol 24: 2699-2705, 1994
10. Kantor AB: The development and repertoire of B-1 cells (CD5 B cells). Immunol Today 12: 389-391, 1991
11. Kawasaki T: Acute febrile mucocccutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children: Clinical observations of 50 cases. Jpn J Allerg 16: 178-222, 1967
12. Kim DS: Serum interleuki-6 in Kawasaki disease. Yonsei Med J 33: 183-188, 1992
13. Kim HS, Noh GW, Kim DS, Lee KY, Lee HS, Lee HK, Lee SI: Decreased CD5+ B cells during the acute phase of Kawasaki disease. Yonsei Med J 37: 52-58, 1996
14. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 170: 827-845, 1989
15. Kobayashi S, Wada N, Kubo M: Antibodies to native type III collagen in the serum of patients with Kawasaki disease. Eur J Pediatr 151: 183-187, 1992
16. Leung DYM: Immunomodulation by intravenous immune globulin in Kawasaki disease. J Allergy Clin Immunol 84: 588-594, 1989
17. Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS: IgM antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma Interferon. J Clin Invest 77: 1428-1435, 1986
18. Leung DYM, Cotran RS, Kurt-Jones E, Burns JC, Newburger JW, Pober JS: Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet 2:1298-1302, 1989
19. Lu P, Zhou XD, Chen SJ, Moorman M, Schoneveld A, Morris S, Finkelman FD, Linsley P, Claassen E, Gause WC: Requirement of CTLA-4 counter receptors for IL-4 but not IL-10 elevated during a primary systemic in vivo immune response. J Immunol 154: 1078-1087, 1995
20. Matsubara T, Furukawa S, Yabuta K: Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions. Clin Immunol Immunopathol 56: 29-36, 1990
21. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR: Interleukin-10. Annu Rev Immunol 11: 165-190, 1993
22. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, Modlin RL: Overexpression of IL-10 in atopic dermatitis. J Immunol 154: 1956-1963, 1995
23. Paul WE: Interleukin 4: A prototypic immunoregulatory lymphokine. Blood 77: 1859-1870, 1990
24. Rousset F, Garcia E, Defrance T, Peronne C, Hsu DH, Kastelein R, Moore KW, Banchereau J: IL-10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89: 1890-1893, 1992
25. Wang SC, Zeevi A, Jordan ML, Simmons RL, Tweardy DJ: FK506, rapamycin, and cyclosporine:effects on IL-4 and IL-10 mRNA levels in a T-helper 2 cell line. Transplant Proc 23: 2920-2922, 1991
26. Yokoda S: Heat shock protein as a predisposing and immunopotentiating factor in Kawasaki disease. Acta Paediatr Jpn 33: 756-764, 1991